A Phase 3 trial of XIAFLEX for cellulite

Trial Profile

A Phase 3 trial of XIAFLEX for cellulite

Planning
Phase of Trial: Phase III

Latest Information Update: 09 Aug 2017

At a glance

  • Drugs Collagenase clostridium histolyticum (Primary)
  • Indications Cellulite
  • Focus Therapeutic Use
  • Sponsors Endo Pharmaceuticals
  • Most Recent Events

    • 09 Aug 2017 According to a BioSpecifics Technologies media release, this study is expected to be initiated towards the end of 2017.
    • 20 Mar 2017 New trial record
    • 15 Mar 2017 According to a BioSpecifics Technologies Corporation media release, trial is expected to be initiated in the second half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top